Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dilutive issuance
confidence 95%
filed 2026-06-09
The filing discloses unregistered issuance of 10,670,000 shares of common stock to five independent contractors as compensation for consulting services, plus an additional 700,000 shares in a settlement agreement, totaling 11,370,000 shares. These are issued as restricted securities under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, which is the classic structure for dilutive private placements. Item 3.02 is the designated disclosure item for unregistered equity sales, and the magnitude of shares issued represents material dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-09
Item 5.07
This Item 5.07 disclosure reports the final results of Avalon GloboCare's June 9, 2026 annual meeting of stockholders, including voting outcomes on six proposals: director elections, auditor ratification, stock incentive plan approval, say-on-pay advisory vote, warrant issuance approval, and reverse stock split authorization. The detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are the core content, making this a textbook shareholder_vote_results event. The warrant issuance and reverse split proposals are particularly material to investors assessing dilution and capital structure risk.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
Bluejay Diagnostics held its Annual Meeting on June 9, 2026, and reported shareholder voting results on four proposals: director elections, authorization of a reverse stock split, approval of Amendment No. 1 to the 2021 Stock Plan (increasing share reserve by 600,000 shares), and ratification of Wolf & Company as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 75%
filed 2026-06-09
Item 5.07
Nuvve held a special meeting of stockholders on June 9, 2026, which was adjourned due to lack of quorum (2,926,864 shares present fell short of the quorum requirement). The filing discloses the procedural outcome of the meeting adjournment and references Item 8.01 for additional details on the stockholder voting matter.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-06-09
Item 5.02
Jay Kim resigned as Co-Chief Executive Officer on June 4, 2026. Jung Jae Lim assumed full CEO responsibilities following Kim's departure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-09
Item 5.07
Shareholders voted on June 3, 2026 to approve an extension of the Company's business combination deadline from June 6, 2026 to June 6, 2027, with up to twelve one-month extensions, along with related amendments to the Investment Management Trust Agreement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-09
The filing discloses the issuance of $458 million aggregate principal amount of 1.250% Convertible Senior Notes due 2032, with an additional $58 million issued upon full exercise of an option by initial purchasers. The Notes are convertible into common stock at an initial conversion price of approximately $7.41 per share (134.9073 shares per $1,000 principal). This is a material dilutive issuance of convertible debt securities that will result in equity dilution upon conversion. While technically a debt issuance under Item 1.01, the convertible feature and substantial principal amount make this a material capital-raising event with significant dilutive potential to existing shareholders.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-09
Item 1.01
This Item 1.01 discloses entry into a Second Amendment to a Merger Agreement dated June 4, 2026, which revises the definition of Fully Diluted Company Shares to include Open World ordinary shares issuable under existing equity agreements. The amendment modifies a material acquisition agreement's key financial terms, making it a material M&A activity event that would affect investor assessment of the transaction structure and valuation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This 8-K Item 5.07 discloses the final voting results from Exagen Inc.'s 2026 annual meeting of stockholders held on June 9, 2026, covering three proposals: election of two Class I directors (Tina S. Nova and Scott Kahn), ratification of BDO USA, P.C. as independent auditor, and advisory approval of named executive officer compensation. The tabulated vote counts for each proposal are the core disclosure required by Item 5.07.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 7.01
The disclosure announces two developments: (1) mobilization of field crews and commencement of the 2026 summer exploration program at the Upper Kobuk Mineral Projects (a material asset for a mineral exploration company), and (2) appointment of a new President at Ambler Metals LLC, the joint venture advancing the project. While the appointment of a new President at the joint venture could suggest exec_appointment, the filing does not clarify whether this person is a named executive of Trilogy itself or merely of the joint venture entity. The primary focus appears to be the operational milestone (field operations underway), which is material to investors in an exploration-stage company but does not fit neatly into the standard taxonomy categories. Classified as other_material given the ambiguity around the appointment's scope and the operational significance of the exploration program announcement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-09
Item 2.02
Designer Brands Inc. issued a press release on June 9, 2026 announcing consolidated financial results for the quarter ended May 2, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The disclosure explicitly references a press release attached as Exhibit 99.1 containing quarterly financial results, which is the standard form of earnings release disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Palantir's June 3, 2026 annual meeting of stockholders. The filing details voting outcomes for six proposals: election of seven directors (all elected), ratification of Ernst & Young as independent auditor, advisory approval of named executive officer compensation, and three stockholder proposals (all rejected). The detailed vote tallies for each nominee and proposal are the core content of the disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 2.03
This Item 2.03 disclosure describes the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Des Moines. While the filing creates a direct financial obligation under Item 2.03, the prose does not disclose a specific debt covenant breach, cross-default, or triggering event that accelerates financial obligations—the hallmarks of covenant_breach. Instead, it describes the routine issuance mechanism and regulatory framework for consolidated obligations. The materiality statement ("although consolidated obligations issuance is material to the Bank") indicates the event is material, but the specific event type does not fit cleanly into the more specific categories; it is best classified as other_material given the regulatory and structural nature of the disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 2.03
This 8-K Item 2.03 discloses the issuance of a $250 million consolidated obligation bond (Variable Single Index Floater, maturing 09/04/2026, trade date 06/05/2026). While Item 2.03 is technically designed for covenant breaches and direct financial obligations, the FHLBank's disclosure here focuses on the creation of a debt obligation through consolidated bond issuance rather than a covenant breach or triggering event. This is material to investors as it represents a significant new debt obligation, but it does not fit cleanly into the more specific event categories (covenant_breach applies to triggering events that accelerate obligations, not routine debt issuance). The filing itself notes that "consolidated obligations issuance is material to the FHLBank," supporting materiality.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-09
Item 2.03
This Item 2.03 disclosure reports the issuance of consolidated obligations (bonds and discount notes) totaling approximately $285 million across multiple tranches with varying maturities, rates, and call features. While Item 2.03 is technically designed for covenant breaches and direct financial obligations, this filing uses it to disclose routine debt issuances by a Federal Home Loan Bank. The Bank explicitly states "consolidated obligations issuance is material to the Bank," and the disclosure is material to investors as it reflects significant new funding activity. However, this does not fit cleanly into the covenant_breach category (no breach is disclosed) and lacks the distress signals typical of that event type. The disclosure is a routine but material debt issuance by a regulated financial institution, best classified as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-09
Item 2.03
This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) totaling approximately $216 million across seven separate issuances with maturities ranging from 2027 to 2031. While Item 2.03 typically signals covenant_breach or debt acceleration events, this filing discloses routine debt issuances in the ordinary course of business by a Federal Home Loan Bank, which is a specialized financial institution whose primary funding mechanism is consolidated obligation issuances. The disclosure is material to investors as it affects the Bank's capital structure and leverage, but does not fit the covenant_breach category (no triggering event or acceleration) and is better classified as other_material given the unique regulatory and operational context of FHLBank debt issuances.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-09
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) totaling approximately $1.325 billion across four separate issuances in early June 2026. While Item 2.03 is the designated section for debt obligations, the taxonomy lacks a specific "debt_issuance" category. The filing explicitly states "consolidated obligations issuance is material to the Bank," and these are material funding activities for a Federal Home Loan Bank. This is classified as "other_material" rather than "covenant_breach" (which addresses defaults) or "ma_activity" (which addresses acquisitions/dispositions).
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
Item 2.03
This Item 2.03 disclosure reports the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds totaling approximately $773 million across multiple issuances with varying maturities (2027–2056) and rate structures. While Item 2.03 is technically a "direct financial obligation," the event does not fit cleanly into the covenant_breach category (no breach alleged) and the bonds are routine consolidated obligations issued by the FHLBank system rather than a discrete triggering event like a debt covenant violation. The disclosure is material to investors assessing the registrant's leverage and obligations, but the nature of the obligation—issuance of consolidated bonds—is a standard operational activity for a Federal Home Loan Bank rather than an exceptional material event.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-09
Item 2.03
This 8-K Item 2.03 discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling approximately $1.5 billion across seven bond issuances with varying maturities (3 months to 20 years) and rate structures. While Item 2.03 is the designated item for debt creation, the taxonomy lacks a specific "debt_issuance" category; the event is material to investors as it represents significant new borrowing by the Bank, but does not fit cleanly into covenant_breach (no breach disclosed) or other more specific categories. The disclosure is routine for an FHLBank's ordinary course funding operations, yet the magnitude and materiality warrant classification as a material event outside the standard taxonomy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-09
Item 2.02
The filing discloses quarterly financial results for the period ended April 30, 2026 via a press release furnished as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which is material to investors as it provides the registrant's reported financial performance and is part of the total mix of information available about the company.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-09
Item 8.01
American Water Works disclosed two significant regulatory rate case settlements: a partial settlement agreement with the California Public Utilities Commission for Cal Am (subsidiary) involving $24–$43 million in incremental annualized revenue depending on CWIP treatment, and a stipulation of settlement with the Virginia State Corporation Commission for Virginia American Water involving a $16 million annualized revenue increase. These regulatory outcomes directly affect the company's future cash flows and profitability from its major operating subsidiaries. While not fitting neatly into the standard 8-K taxonomy (not M&A, not litigation, not impairment), the materiality of rate case outcomes to a regulated utility's financial performance and investor assessment warrants classification as a material event outside the more specific categories.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of CervoMed's 2026 Annual Meeting of Stockholders held on June 8, 2026. The filing presents voting results for four proposals: election of eight directors, ratification of RSM US LLP as auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2025 Equity Incentive Plan. All proposals passed with the requisite majorities. This is a material disclosure as it documents shareholder approval of governance and compensation matters.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-09
Item 4.01
This is a clear auditor change under Item 4.01. Assure CPA, LLC resigned as the independent registered public accounting firm effective June 3, 2026, following its acquisition by Sadler Gibb & Associates, LLC. The Board appointed Sadler Gibb as the new independent registered public accounting firm on June 5, 2026. The filing explicitly confirms no disagreements, reportable events, or adverse audit opinions, indicating a routine transition rather than a dispute-driven change.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-09
Item 2.02
The filing discloses a press release announcing financial results for the fourth fiscal quarter and full fiscal year ended March 29, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a classic earnings release disclosure, which is material to investors as it provides the registrant's periodic financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-09
Item 2.02
The filing discloses a press release announcing financial results for the first quarter ended April 30, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-06-09
Item 3.01
Professional Diversity Network received written notification from Nasdaq on June 5, 2026, that it failed to comply with Nasdaq Listing Rule 5550(a)(2) due to its closing bid price falling below $1.00 per share for 30 consecutive business days. The company has been granted a 180-calendar day compliance period until December 2, 2026, to regain compliance, with potential delisting if it fails to do so. This is a classic delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-09
Item 1.01
On June 3, 2026, the Company entered into a Redemption Agreement to redeem and cancel all 1,153 outstanding shares of Series C Senior Convertible Preferred Stock for $922,400 in cash and termination of the underlying Equity Purchase Agreement. This material modification of the Company's equity structure eliminates a significant preferred equity position and was completed on June 8, 2026.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-09
Item 3.03
The Company amended its Articles of Incorporation to modify security holder rights, including the cancellation of Series AAA-2 and Series C preferred stock designations. While the cancellation of Series C relates to the redemption transaction, the broader modifications to security holder rights disclosed in Item 3.03 represent material changes to the Company's capitalization structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-09
Item 1.01
LiqTech entered into an Underwriting Agreement on June 4, 2026, for a registered public offering of 20,000,000 shares of common stock at $1.00 per share, with a 3,000,000 share over-allotment option. The offering closed on June 8, 2026, generating approximately $18.0 million in net proceeds for debt repayment and working capital.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-09
Item 3.02
LiqTech issued 3,000,000 shares of common stock on June 8, 2026, in a private placement exempt under Section 4(a)(2) and Rule 506(b), in exchange for cancellation of $3.0 million in senior promissory notes.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-09
Item 2.02
Skillsoft disclosed financial results for the fiscal quarter ended April 30, 2026 via a press release furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-09
Item 1.01
NexPoint's operating partnership entered into a Loan Purchase and Sale Agreement on June 5, 2026, to acquire a $27.2 million term loan (the Waterford Loan) from NexBank Capital. This represents a material capital deployment and acquisition of a financial asset that management has identified as the "first deployment of capital in the Delaware statutory trust bridge-lending program." The transaction is funded via the company's revolving credit facility and involves assumption of the lender role under the underlying credit agreement, constituting a material definitive agreement under Item 1.01.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
AXT Inc. held its Annual Meeting of Stockholders on June 4, 2026, with shareholders voting on five proposals: election of two Class I directors (Dr. Morris Young and Dr. David Chang), advisory vote on executive compensation, ratification of BPM as independent auditor, approval of an amendment to increase authorized common shares from 70 million to 120 million, and approval of an adjournment proposal. The filing discloses the voting results and outcomes for each matter.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 9, 2026. The filing reports voting outcomes for two proposals: (1) election of directors Jenn Adams and Charles J. Casamento, and (2) ratification of Grant Thornton LLP as independent auditor. The detailed vote tallies (For, Against, Withheld, Abstain, Broker Non-Votes) are presented in tabular form, which is the standard format for Item 5.07 disclosures of shareholder meeting results.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-06-09
Item 2.02
Uranium Energy Corp issued a news release on June 9, 2026 disclosing financial highlights and operational updates for the third quarter of fiscal year 2026 ended April 30, 2026, including the filing of its Form 10-Q with interim condensed consolidated financial statements and management's discussion and analysis.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from the annual meeting held June 9, 2026. The filing reports voting outcomes on four proposals: election of director Robert E. Cauley (4,126,106 for), ratification of BDO USA as auditor (7,408,328 for), approval of Rights Agreement amendment (4,139,041 for), and advisory vote on executive compensation (4,120,960 for). All proposals passed with substantial majorities, making this a material disclosure of shareholder actions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-09
Item 5.02
The disclosure centers on the appointment of Ryan Panopio as Chief Investment Officer effective June 3, 2026, a newly created executive role. While the filing also includes compensatory details (base salary of $380,000, equity awards, and incentive targets), the principal action disclosed is the appointment itself. The appointment is material given the strategic importance emphasized by the CEO and the executive's substantial experience in real estate investment and capital markets, which directly supports the Company's stated growth objectives.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-09
Item 1.01
VolitionRx entered into a securities purchase agreement on June 7, 2026, to sell 2,960,000 shares of common stock and 1,480,000 common stock purchase warrants at $1.55 per unit, raising approximately $4.1 million in net proceeds with additional dilutive potential from warrant exercises.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-09
Brand Engagement Network Inc. entered into definitive agreements on June 8, 2026, establishing INTERVENT Health AI, Inc., a 50/50 joint venture with INTERVENT International, LLC. The filing discloses material terms including exclusive five-year North American commercialization arrangements, revenue-sharing provisions (35% to BEN from North American activities, 50% from international reseller arrangements), governance structure, and significant equity issuances (32.5 million Class A shares to each party plus 5 million Class B Preferred shares). This constitutes a material acquisition/formation activity under Item 1.01 that would affect a reasonable investor's assessment of the company's strategic direction and financial interests.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-09
The filing discloses multiple executive appointments on June 2, 2026: Loïc Gautier as Chief Financial Officer (US$150,000 annual base salary), Binglin Yu as Chief Technology Officer (RMB 55,000/month), and Hongwei Zhang as Chief Revenue Officer (RMB 55,000/month). While the filing also includes the departure of Chief Operating Officer Ade Irawan, the principal focus and substance of the disclosure centers on the three new C-suite appointments with detailed biographical information and compensation terms, making exec_appointment the most salient event type.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-09
The filing discloses the appointment of James Sapirstein as Chief Executive Officer of Cocrystal Pharma, effective June 3, 2026. While the disclosure also includes compensatory arrangements (base salary of $265,000, performance bonus, and stock option grants), the principal disclosed action is the appointment of a new CEO to replace co-CEOs Sam Lee and James Martin. This is a material executive change affecting the company's leadership structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-09
Item 1.01
22nd Century Group issued new warrant inducement agreements (Inducement Warrants) to purchase common stock at a significantly reduced exercise price of $0.4626 compared to the original $3.57 exercise price. The Inducement Warrants and underlying shares are unregistered equity securities issued in reliance on Section 4(a)(2) exemption, materially affecting shareholder ownership and dilution.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-06-09
Item 3.03
The Company effected a 1-for-20 reverse stock split solely to restore compliance with NASDAQ Capital Market's continued listing standards. This action addresses a material listing compliance failure and represents a significant delisting risk event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-09
Item 1.01 discloses entry into a material definitive agreement on June 3, 2026: a limited liability company agreement establishing a joint venture (Soluna MB KK II JVCo, LLC) between Soluna HPC KK II HoldCo, LLC and DC Kati Venture LLC to develop and operate a multi-phase data center project ("Kati 2") in Texas. The Soluna Member is contributing approximately $3.5 million in initial funding plus committed capital of up to $21 million for Phase I (100 MW) and Phase II (250 MW) development, with defined return thresholds (14% IRR and $100,000 per Gross PPA MW) before profit-sharing. This constitutes a material joint venture investment and operational commitment that would affect investor assessment of the company's capital allocation and growth strategy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-09
Applied Digital announced a $1.59 billion private offering of senior secured notes due 2031 by its subsidiary APLD ComputeCo 3 LLC, disclosed under Item 8.01. While technically debt rather than equity, this represents a material capital raise that will dilute existing shareholders' ownership percentage and is disclosed as a significant financing event. The offering is substantial in size and intended to fund major infrastructure development (150 MW at Ellendale) and repay bridge financing.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
The filing discloses entry into a long-term strategic agreement with Frankfort Plastics to supply 40,000 tons per year of polyolefin plastic waste to the Company's Cedar Port Waste to Fuels facility. While this represents a material commercial arrangement that would affect investor assessment of the company's operations and revenue prospects, it does not fit cleanly into the M&A taxonomy (no acquisition, merger, or change of control) and is disclosed under Item 8.01 (Other Events) rather than Items 1.01 or 2.01. The supply agreement is material but lacks the structural characteristics of a traditional M&A transaction.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-09
The filing discloses an unregistered sale of 79,618 shares of common stock to CEO Steven Rossi on June 5, 2026, at $0.6280 per share for $50,000.10, relying on Section 4(a)(2) exemption. Although the purchase price was satisfied through offset of accrued bonus compensation rather than cash, this is a dilutive equity issuance to an insider that would materially affect shareholder ownership and is properly classified under Item 3.02 (Unregistered Sales of Equity Securities).
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-09
The filing's primary disclosure under Item 1.01 is entry into a Binding Letter of Intent with FORCARA, LLC on June 8, 2026, establishing a framework for a strategic business relationship and definitive transaction whereby FORCARA would become part of the Company's operating platform. Although the final acquisition structure and terms remain subject to due diligence and definitive agreements, the binding interim joint venture with revenue-sharing (50/50 EBITDA split, $12,500/month management fee) and exclusivity provisions constitute a material M&A-related commitment. The filing also discloses complementary governance actions (Series K issuance, board appointment, Series R preferred stock authorization) supporting the strategic repositioning, but the LOI with FORCARA is the central material event.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-09
The filing discloses two distinct events under Item 8.01: (1) successful field performance and power generation from a PowerBuoy® system deployed for U.S. Coast Guard maritime domain awareness operations off San Diego, and (2) an inducement grant to a newly hired employee. The operational achievement represents a material milestone for a wave-energy technology company, though the filing provides minimal detail. The employee grant is routine compensation. Neither event fits the specific taxonomy categories—this is neither an earnings release (no financial results), exec_appointment (no named officer), exec_compensation (routine inducement grant), nor material_litigation. The operational success is material to investors assessing the company's technology viability and commercialization progress.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-09
The filing discloses results of Sanara MedTech's Annual Meeting of Shareholders held on June 4, 2026, under Item 5.07. The company reports voting outcomes for four proposals: election of nine directors, ratification of auditor Weaver and Tidwell L.L.P., advisory approval of named executive officer compensation, and frequency of future advisory votes on compensation. All proposals received sufficient votes for approval, with detailed vote tallies provided for each nominee and proposal.
View raw filing on EDGAR →